Key result
Low socio-economic status is linked to ~3-fold higher prevalence in stage 5 CKD vs controls.
Why the study?
Chronic kidney disease is a growing public health burden in Nigeria, prompting an evaluation of demographic, socio-economic, anthropometric, and traditional clinical diagnostic data among CKD patients with hypertension and diabetes in Ekiti-State.
Cross-Sectional (n=270)
Answers are grounded in this paper and cite their sources.
Low socio-economic status, advancing age, and comorbid hypertension and diabetes are strongly associated with severe renal impairment among CKD patients in Ekiti-State, Nigeria, underscoring the need for routine eGFR reporting.
Background: Chronic kidney disease (CKD) is a growing public health burden in many low and middle-income countries including Nigeria. This study evaluated demographic, socio-economic, and anthropometric data, as well as results of traditional clinical diagnostic tests among chronic kidney disease patients living with hypertension and diabetes in EkitiState, Nigeria. Methods: A cross-sectional study was conducted among 270 adult participants. Participants were grouped based on their eGFR values into CKD stage 1 (n=29), CKD stage 2 (n=41), CKD stage 3 (n=35), CKD stage 4 (n=15), CKD stage 5 (n=50), and Control (n=100). Demographic, socio-economic, and anthropometric data, as well as serum urea and creatinine values were analyzed. Results: Participants in CKD stage 5 (73.50 ± 5.64) were significantly older compared to those in CKD stage 1 (50.10 ± 6.20) (F=31.42, p<0.001). Low-income earners (<₦30,000/month) comprised 64.0% of participants in CKD stage 5 compared to 22.0% of controls (χ²=38.12, p<0.001). Participants with combined hypertension and diabetes had the most severe clinical profiles, with mean systolic blood pressure of 162.40 ± 18.50mmHg, serum urea of 14.60 ± 6.80 mmol/L, serum creatinine of 284.60 ± 112.40 µmol/L, and eGFR of 28.60 ± 16.40 mL/min/1.73m² (p<0.001). Socio-economic indices correlated positively with eGFR (r=+0.458, p<0.001) and negatively with serum creatinine (r=-0.436, p<0.001). Conclusion: Low socio-economic status, advancing age, and dual burden of hypertension and diabetes drive progression of renal impairment among CKD patients in Ekiti-State. Standard creatinine estimation misses early-stage decline, highlighting the urgent need for routine eGFR reporting and subsidized medical testing.
No takes yet. Share an insight, caveat, or question.
Adeleke et al. (2026) conducted a cross-sectional in Chronic kidney disease among hypertensive and diabetic patients (n=270). Low socio-economic status and combined hypertension and diabetes vs. Control group (n=100) and higher socio-economic status was evaluated on Prevalence of low-income status (<₦30,000/month) in CKD stage 5 vs Control, and correlation of socio-economic indices with eGFR (r = +0.458, p=<0.001). Low socio-economic status (<₦30,000/month) was more common in CKD stage 5 than controls and correlated with lower eGFR.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: